K-115 clinical pharmacology study
Phase 2
- Conditions
- diabetic retinopathy , diabetic macular edema
- Registration Number
- JPRN-jRCT2080222406
- Lead Sponsor
- Kowa Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 5
Inclusion Criteria
1.Patients with type 2 diabetes mellitus
2.Patients with nonproliferative diabetic retinopathy
3.Patients with diabetic macular edema
Exclusion Criteria
1.Patients whose best corrected visual acuity is less than 0.1
2.Patients who are not able to abstain medications that have the potential to affect on the evaluation of K-115
3.Patients with any trouble to measure ocular blood flow and retinal thickness
etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method